Global 3D printed drugs Market Size Study, By Drug (Spritam and Others) and Regional (US and Rest of the World) Forecasts, 2017-2025

For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global 3D printed drugs market valued at approximately USD XX Million in 2016 is anticipated to grow with a healthy growth rate of XX% over the forecast period 2017-2025. 3D printed drugs are created by 3D printing technology which is used to treat patients who suffer from dysphagia. This medicine is easy to swallow and helpful for patients suffering from dysphagia. Increase in demand for fast soluble drugs which can disperse easily in the mouth is the key factor that gives growth to the global 3D printed drugs market. Furthermore, rising incidence of epilepsy cases continues technological developments in 3D printing technique, and growing awareness for 3D printing technology in the developing countries are the major drivers of the market. However, concerns such as blueprint hacking and mislabeling of the blueprint are going to hamper the market growth. Moreover, a dicey regulatory scenario is another major restraint.

Global 3D Printed Drugs Market In 2016, Sprite is the first 3D printed drug receive approval from the FDA. It is launched by Aprecia Pharmaceuticals. This medicine is currently active only in the U.S. region.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

Drug:

  • Spritam
  • Others

Regions:

  • North America
    • The U.S.
  • Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year – 2015

Base year – 2016

Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market Aprecia Pharmaceuticals, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, LLC, 3D Printer Drug Machine, and FabRx Ltd. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the 3D printed drugs Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

 

Chapter 1.           Research Methodology

1.1.         Research Process

1.1.1.     Data Mining

1.1.2.     Analysis

1.1.3.     Market Estimation

1.1.4.     Validation

1.1.5.     Publishing

1.2.         Research Assumption

Chapter 2.           Global 3D printed drugs Market Definition & Scope

2.1.         Objective of The Study

2.2.         Market Definition

2.3.         Scope of The Study

2.4.         Years Considered for The Study

2.5.         Currency Conversion Rates

2.6.         Report Limitation

Chapter 3.           Executive Summary

3.1.         Key Trends

3.2.         Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Million)

Chapter 4.           Global 3D printed drugs Industry Dynamics

4.1.         Growth Prospects

4.1.1.     Drivers

4.1.2.     Restraints

4.1.3.     Opportunities

4.2.         Industry Analysis

4.2.1.     Porter’s 5 Force Model

4.2.2.     PEST Analysis

4.2.3.     Value Chain Analysis

4.3.         Analyst Recommendation & Conclusion

Chapter 5.           Global 3D printed drugs Market by Drugs

5.1.         Market Snapshot

5.2.         3D printed drugs Market, Sub Segment Analysis

5.2.1.     Spritam

5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Million)

5.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

5.2.2.     Others

5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Million)

5.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)

Chapter 6.           Global 3D printed drugs Market, Regional Analysis

6.1.         3D printed drugs Market, Regional Market Snapshot (2015-2025)

6.2.         North America 3D printed drugs Market Snapshot

6.2.1.     U.S. 3D printed drugs Market Size Estimates & Forecasts, 2015-2025 (USD Million)

6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Million)

6.2.1.2. Spritam breakdown estimates & forecasts, 2015-2025 (USD Million)

6.3.         Rest of The World 3D printed drugs Market Snapshot

6.3.1.     Market estimates & forecasts, 2015-2025 (USD Million)

6.3.2.     Spritam breakdown estimates & forecasts, 2015-2025 (USD Million)

Chapter 7.           Competitive Intelligence

7.1.         Company Market Share (Subject to Data Availability)

7.2.         Top Market Strategies

7.3.         Company Profiles

7.3.1.     Aprecia Pharmaceuticals

7.3.1.1. Overview

7.3.1.2. Financial (Subject to Data Availability)

7.3.1.3. Product Summary

7.3.1.4. Recent Developments

7.3.2.     GlaxoSmithKline Plc.

7.3.3.     Hewlett Packard Caribe

7.3.4.     BV

7.3.5.     FabRx Ltd

7.3.6.     3D Printer Drug Machine

 

The research for global 3D printed drugs market focuses deeply on the entire value chain of the market. However, the market size estimates are purely based on the consumer side of the value chain wherein the market sizes have been calculated by analyzing the average demand for 3D printed drugs.

The revenue for global 3D printed drugs market is calculated as sum market sizes of different segments such as drugs and regions. Further, some other key data points considered to calculate the revenue for global 3D printed drugs market includes:

  • Revenues from key companies
  • Key company market share analysis
  • Consumer spending analysis
  • Patent analysis

An extensive primary and secondary research has been conducted on key industry people, through questionnaires, telephonic conversations, email conversations, and interviews to verify the market estimations. Various government websites/portals and paid data sources are considered as a key source of secondary research.

We utilize a combination of bottom-up & top-down methodology for market estimations & forecasts. Additionally, we employ data triangulation techniques to verify each of the market estimates and forecasts through primary interviews and feedbacks.

All the estimates are derived from simulation models which is our proprietary technique. Each of these models is different from each other are a combination of correlation, regression and time series analysis. Each of these models is basically divided into two types namely economic and technological. Economical models are used to determine short-term market estimates and technological models are used for long-term estimates & forecasts.  

 


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,150

Enterprise License – $5,550

Loading…